1045 related articles for article (PubMed ID: 36864689)
1. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
2. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
Wang Y; Wang J; Yan Z; Liu S; Xu W
Front Immunol; 2023; 14():1240517. PubMed ID: 37809092
[TBL] [Abstract][Full Text] [Related]
3. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
4. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
5. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study.
Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L
Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization study reveals a population-specific putative causal effect of type 2 diabetes in risk of cataract.
Zhang H; Xiu X; Xue A; Yang Y; Yang Y; Zhao H
Int J Epidemiol; 2022 Jan; 50(6):2024-2037. PubMed ID: 34999863
[TBL] [Abstract][Full Text] [Related]
7. Shared Genetic Risk Factors for Multiple Sclerosis/Psoriasis Suggest Involvement of Interleukin-17 and Janus Kinase-Signal Transducers and Activators of Transcription Signaling.
Patrick MT; Nair RP; He K; Stuart PE; Billi AC; Zhou X; Gudjonsson JE; Oksenberg JR; Elder JT; Tsoi LC
Ann Neurol; 2023 Aug; 94(2):384-397. PubMed ID: 37127916
[TBL] [Abstract][Full Text] [Related]
8. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.
Zheng J; Zhang Y; Zhao H; Liu Y; Baird D; Karim MA; Ghoussaini M; Schwartzentruber J; Dunham I; Elsworth B; Roberts K; Compton H; Miller-Molloy F; Liu X; Wang L; Zhang H; Smith GD; Gaunt TR
EBioMedicine; 2022 Jul; 81():104112. PubMed ID: 35772218
[TBL] [Abstract][Full Text] [Related]
9. Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.
Wu Y; Wang Z; Yang Y; Han C; Wang L; Kang K; Zhao A
Front Pharmacol; 2023; 14():1266782. PubMed ID: 37745050
[No Abstract] [Full Text] [Related]
10. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Lu H; Wu PF; Zhang W; Liao X
Front Immunol; 2021; 12():647588. PubMed ID: 33936066
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer Disease and Epilepsy: A Mendelian Randomization Study.
Fang Y; Si X; Wang J; Wang Z; Chen Y; Liu Y; Yan Y; Tian J; Zhang B; Pu J
Neurology; 2023 Jul; 101(4):e399-e409. PubMed ID: 37225432
[TBL] [Abstract][Full Text] [Related]
12. A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.
Ge A; Sun Y; Kiker T; Zhou Y; Ye K
J Neuroimmunol; 2023 Jun; 379():578105. PubMed ID: 37207441
[TBL] [Abstract][Full Text] [Related]
13. Plasma circulating vitamin C levels and risk of multiple sclerosis: a two-sample Mendelian randomization analysis.
Peng H; Wu X; Wen Y; Lin J
Mult Scler Relat Disord; 2021 Nov; 56():103267. PubMed ID: 34610567
[TBL] [Abstract][Full Text] [Related]
14. The potential protective role of Parkinson's disease against hypothyroidism: co-localisation and bidirectional Mendelian randomization study.
Lei J; He W; Liu Y; Zhang Q; Liu Y; Ou Q; Wu X; Li F; Liao J; Xiao Y
Front Aging Neurosci; 2024; 16():1377719. PubMed ID: 38808034
[TBL] [Abstract][Full Text] [Related]
15. Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians.
Xiu X; Zhang H; Xue A; Cooper DN; Yan L; Yang Y; Yang Y; Zhao H
BMC Med; 2022 Aug; 20(1):300. PubMed ID: 36042491
[TBL] [Abstract][Full Text] [Related]
16. Genetic analyses identify brain imaging-derived phenotypes associated with the risk of amyotrophic lateral sclerosis.
Wang Y; Shen O; Xu Q; Sun L; Jia Y; Liu Y; He Y; Chang X; Guo D; Shi M; Chen GC; Zheng J; Zhu Z
Cereb Cortex; 2024 Jan; 34(1):. PubMed ID: 38112636
[TBL] [Abstract][Full Text] [Related]
17. Chickenpox and multiple sclerosis: A Mendelian randomization study.
Zhu G; Zhou S; Xu Y; Gao R; Zhang M; Zeng Q; Su W; Wang R
J Med Virol; 2023 Jan; 95(1):e28315. PubMed ID: 36380510
[TBL] [Abstract][Full Text] [Related]
18. Alcohol, coffee consumption, and smoking in relation to migraine: a bidirectional Mendelian randomization study.
Yuan S; Daghlas I; Larsson SC
Pain; 2022 Feb; 163(2):e342-e348. PubMed ID: 35029599
[TBL] [Abstract][Full Text] [Related]
19. Potential drug targets for myocardial infarction identified through Mendelian randomization analysis and Genetic colocalization.
Wu J; Fan Q; He Q; Zhong Q; Zhu X; Cai H; He X; Xu Y; Huang Y; Di X
Medicine (Baltimore); 2023 Dec; 102(49):e36284. PubMed ID: 38065874
[TBL] [Abstract][Full Text] [Related]
20. Basal metabolic rate and risk of multiple sclerosis: a Mendelian randomization study.
Liu C; Lu Y; Chen J; Qiu W; Zhan Y; Liu Z
Metab Brain Dis; 2022 Aug; 37(6):1855-1861. PubMed ID: 35543713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
